The J&J Vaccine Suspension’s Impact on the US

Johnson and Johnson has paused its vaccine rollout after multiple cases of severe blood clotting. Talking Points Analyst Natalie Fahmy breaks down how this pause may have the potential to up-end trust in the vaccination process.